Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes (anti IL-1)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00947427
First received: July 24, 2009
Last updated: May 28, 2013
Last verified: May 2013